Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 134,836 | 0.2% | 297,414 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 120,851 | 0.2% | 308,577 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 151,489 | 0.2% | 340,272 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 167,649 | 0.2% | 345,796 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 145,912 | 0.2% | 362,334 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 167,186 | 0.2% | 359,479 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 182,122 | 0.2% | 388,552 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 163,800 | 0.2% | 391,856 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 166,429 | 0.2% | 409,026 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 153,609 | 0.2% | 441,734 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 165,114 | 0.2% | 469,193 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 145,504 | 0.2% | 461,814 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 136,512 | 0.2% | 472,718 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 136,226 | 0.2% | 470,490 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 138,283 | 0.2% | 490,732 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 126,938 | 0.1% | 486,410 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 107,571 | 0.1% | 489,848 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 91,309 | 0.1% | 503,383 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 100,237 | 0.1% | 497,135 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 105,629 | 0.1% | 491,547 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 120,912 | 0.1% | 511,600 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 146,782 | 0.2% | 539,400 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 164,179 | 0.2% | 565,530 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 135,454 | 0.2% | 569,255 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 124,884 | 0.1% | 570,375 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 67,736 | 0.1% | 715,425 | 6/30/2014 |
| 2014 Q1 | 5/5/2014 | 52,151 | 0.1% | 737,425 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 54,791 | 0.1% | 737,425 | 12/31/2013 |